Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
Micro Penny Stocks, Penny Stocks $0.10 & Under
»
CLBE-CALBATECH INC bio-tech
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is not enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by QuestSolver: [QB] some brief DD for CLBE 15375 Barranca Parkway Irvine, CA 92618 (Map)Phone: 949-450-9910 Fax: 949-450-9954 http://www.calbatech.com CalbaTech now looks to build a portfolio by buying companies that develop new technologies to sell or license; it also targets universities that are planning to license technology developed in academic labs. The firm is interested in products that will generate sales or licensing revenue within two years and need less than $1 million. Among its acquisitions are [b]MolecularWare and iStem Technologies[/b] MoleculareWare helps scientists have the wherewithal to keep their As, Cs, Gs, and Ts straight. The firm, a subsidiary of CalbaTech, offers bioinformatics software and other products to integrate the volumes of data produced from high throughput screening, combinatorial synthesis, and other methods of genomics research. Its DigitalGENOME suite consists of three software programs. DesignerDG can configure microplates and track the liquids used in the microplate wells. AnalyzerDG analyzes images and manages data from microarrays; the software can be used as part of DigitalGENOME or on its own. IntegratorDG can integrate data stored in a variety of database platforms, including platforms from Oracle and Microsoft. http://www.calbatech.com/shareholder.pdf Drug Week, 09/15/2005 07:18:31 PM EDT) CalbaTech, Inc., announced that revenues for the 6 months ended June 30, 2005, totaled $625,345, [b]up from $58,217 for the same period in 2004.[/b] Revenues for the second quarter totaled $310,525, compared to revenues of $40,941 for the same period in 2004. (Biotech Week, 09/15/2005 07:08:23 PM EDT) (Medical Devices & Surgical Technology Week) Biotech Week CalbaTech, Inc., (CLBE) said its wholly owned subsidiary, K-D Medical, Inc.,[b] Columbia, Maryland, is acquiring a new facility that has two validated, Class 100 Clean Rooms for additional manufacture of products.[/b] K-D Medical is a primary vendor to the National Institutes of Health (NIH) and currently sells products to every major pharmaceutical company in the U.S. K-D Medical's founder, John Powers, said the new Clean Rooms, plus a complete quality control laboratory, will allow the company to manufacture a higher quality product as well as expand the current custom product offering, better serving the needs of both existing and new customers. [b]"This is a very good position for us, as we increase sales to the National Institutes of Health, major universities and pharmaceutical companies," Powers said. [/b] "These new facilities allow K-D Medical to open new manufacturing and Clean Room leasing opportunities with pharmaceutical and other companies, opportunities that did not exist prior to this," said James DeOlden, chairman and CEO, CalbaTech. "We are very bullish on our subsidiary's future." This article was prepared by Biotech Week editors from staff and other reports. Copyright 2005, Biotech Week via NewsRx.com. NewsRx.com) -- CalbaTech, Inc., (CLBE) has retained the services of Agora Investor Relations Corp. (Agora). The objective of this agreement is two-fold. First, to create effective communication between CalbaTech, its shareholders and the investment community through Agora's Internet based investor relations system. Effective immediately, a customized and monitored CalbaTech IR HUB will allow both CalbaTech and Agora to communicate with all investors simultaneously, anytime and in real-time, while providing shareholders with equal access and complete transparency to all investor relations communications. The IR HUB will also provide one-click access to the CalbaTech broker fact sheet, company profile, five most recent press releases, e-mail list registration, latest stock quote and chart information and an executive audio address updated quarterly. In addition, the IR HUB provides investors with a monitored discussion forum for the purposes of constructive and high-quality discussion about the company that is free of spam, bashing, hyping and profanity. Second, Agora will be fully responsible for creating, implementing and executing an investor relations strategy, the consolidation of which will save management a considerable amount of time, effort and expense, allowing them to focus on core business operations, while significantly improving shareholder communications. CalbaTech CEO James DeOlden stated, [b]"We believe that the time is right to begin an investor awareness program. [/b]CalbaTech has been executing its business plan, and given the company's recent developments and the excitement being generated in the life sciences Industry, we believe the time has now come to significantly increase our communications with shareholders and the investment community." This article was prepared by Biotech Week editors from staff and other reports. Copyright 2005, Biotech Week via NewsRx.com. [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2